Hypertension in autosomal dominant polycystic kidney disease: a meta-analysis

Matko Marlais1, Oliver Cuthell2, Dean Langan1

  • 1Institute of Child Health, University College London, London, UK.

Insights

Hypertension affects 20% of children with autosomal dominant polycystic kidney disease (ADPKD). Regular blood pressure monitoring is recommended for early detection in at-risk children.

Area of Science:

  • Nephrology
  • Pediatrics
  • Genetics

Background:

  • Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic disorder.
  • Hypertension is a known complication of ADPKD, but its prevalence in childhood is not well-established.

Purpose of the Study:

  • To systematically review and meta-analyze the prevalence of hypertension in children and young individuals (<21 years) diagnosed with ADPKD.
  • To determine the prevalence of associated conditions like proteinuria and reduced renal function in this pediatric population.

Main Methods:

  • A systematic literature search was conducted across MEDLINE and EMBASE from 1980 to 2015.
  • Studies were independently selected by two authors, including observational series with over 15 children.
  • Meta-analysis was used to calculate the weighted mean prevalence of hypertension, proteinuria, and reduced renal function.

Main Results:

  • The meta-analysis included 14 studies encompassing 928 children with ADPKD.
  • A significant prevalence of hypertension was found, estimated at 20% (95% CI 15% to 27%).
  • The prevalence of proteinuria was estimated at 20% and reduced renal function at 8% among children with ADPKD.

Conclusions:

  • The study estimates that 20% of children with ADPKD experience hypertension.
  • A substantial number of children with ADPKD may remain undiagnosed due to lack of regular follow-up.
  • Regular blood pressure measurement is recommended for all children at risk for ADPKD.
Abstract

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.7K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1000
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
709
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.3K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
586
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
292